Literature DB >> 20387837

Role of guanidyl moiety in the insertion of arginine and Nalpha-benzoyl-L-argininate ethyl ester chloride in lipid membranes.

A C Fonseca1, M A Frías, A M Bouchet, S Jarmelo, P N Simões, R Fausto, M H Gil, F Lairion, E A Disalvo.   

Abstract

Guanidyl moieties of both arginine (Arg) and N(alpha)-benzoyl-L-argininate ethyl ester chloride (BAEE) are protonated in all environments studied, i.e., dry solid state, D(2)O solutions, and dry and hydrated lipids as suggested by DFT(B3LYP)/6-31+G(d,p) calculations. Arg and BAEE are able to insert in the lipid interphase of both DMPC and DOPC monolayers as revealed by the observed decrease in the membrane dipole potential they induce. The larger decrease in the dipole potential induced by BAEE, compared to Arg, can be explained partially by the higher affinity of the hydrophobic benzoyl and ethyl groups for the membrane phase, which allows an easier insertion of this molecule. FTIR studies indicate that the guanidyl moiety of Arg is with all probability facing the hydrophobic part of the lipids, whereas in BAEE this group is facing the water phase. Zeta potential measurements provide a direct evidence that Arg orients in the lipid interphase of phosphatidylcholine (PC) bilayers with the negative charged carboxylate group (-COO-) toward the aqueous phase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20387837     DOI: 10.1021/jp101007b

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  2 in total

1.  Dynamic Light Scattering Based Microelectrophoresis: Main Prospects and Limitations.

Authors:  Vuk Uskoković
Journal:  J Dispers Sci Technol       Date:  2012-12-01       Impact factor: 2.262

2.  Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy.

Authors:  Guosheng Wang; Weilei Hu; Haiqiong Chen; Xin Shou; Tingting Ye; Yibing Xu
Journal:  Cancers (Basel)       Date:  2019-10-14       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.